Metabolic Syndrome, Obesity
Conditions
Keywords
Monocyte subsets, Obesity, Metabolic Syndrome
Brief summary
Obesity is associated with a chronic low-grade inflammation characterized by macrophage infiltration in adipose tissue that induces insulin resistance and the appearance of metabolic syndrome (MS). The aim of the study was the investigation of whether circulating monocyte subsets are differentially regulated in MS.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
\-
Exclusion criteria
Age less than 18 years old, pregnancy, breast feeding, kidney disease, liver disease, gastrointestinal disease, malignancy, any endocrine disorder or metabolic disease, other than obesity or type 2 diabetes mellitus (T2DM), alteration of body weight (BW) by up of 5% of the initial BW during the last 3 months, any state of stress or systemic inflammation and taking any of the following drugs, within 3 weeks prior to the start of the study: hypolipidemic agents, antidiabetics, drugs for weight loss, nonsteroidal antiinflammatory drugs, glucocorticoids.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Monocyte subsets | Baseline measurement | Absolute blood count of classical (Mon1A), intermediate (Mon2A) and nonclassical (Mon3A) monocyte subsets wil be measured by flow cytometry. |
Countries
Greece